Ergoteles LLC Regenxbio Inc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$17.23 - $21.71 $67,782 - $85,407
3,934 Added 26.08%
19,016 $380,000
Q1 2023

May 10, 2023
BUY
$18.08 - $24.55 $272,682 - $370,263
15,082 New
15,082 $285,000
Q3 2021

Nov 15, 2021
SELL
$29.09 - $45.68 $215,266 - $338,032
-7,400 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$32.46 - $40.48 $240,204 - $299,552
7,400 New
7,400 $287,000

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
42M
Call Options Held
80.6K
Put Options Held
55.2K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $458M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email